Quantbot Technologies LP Sells 12,390 Shares of Xylem Inc. (NYSE:XYL)

Quantbot Technologies LP trimmed its position in shares of Xylem Inc. (NYSE:XYLFree Report) by 60.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,099 shares of the industrial products company’s stock after selling 12,390 shares during the quarter. Quantbot Technologies LP’s holdings in Xylem were worth $1,094,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of XYL. EverSource Wealth Advisors LLC raised its stake in shares of Xylem by 68.8% in the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock worth $25,000 after buying an additional 77 shares during the period. Bangor Savings Bank lifted its holdings in Xylem by 56.7% during the third quarter. Bangor Savings Bank now owns 235 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 85 shares in the last quarter. Mark Sheptoff Financial Planning LLC bought a new position in shares of Xylem in the second quarter worth approximately $33,000. Blue Trust Inc. increased its stake in shares of Xylem by 1,185.7% in the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 249 shares in the last quarter. Finally, Assetmark Inc. raised its position in shares of Xylem by 3,887.5% during the 3rd quarter. Assetmark Inc. now owns 319 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 311 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Price Performance

XYL stock opened at $126.75 on Friday. Xylem Inc. has a 52 week low of $102.67 and a 52 week high of $146.08. The firm has a market capitalization of $30.79 billion, a P/E ratio of 37.06, a price-to-earnings-growth ratio of 2.31 and a beta of 1.05. The company has a fifty day simple moving average of $129.37 and a two-hundred day simple moving average of $133.78. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, hitting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company had revenue of $2.10 billion during the quarter, compared to analyst estimates of $2.17 billion. During the same quarter last year, the business posted $0.99 earnings per share. The firm’s revenue was up .2% on a year-over-year basis. Analysts anticipate that Xylem Inc. will post 4.23 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th will be given a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a yield of 1.14%. Xylem’s dividend payout ratio is presently 42.11%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. TD Cowen cut their price target on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research note on Wednesday, November 6th. Royal Bank of Canada dropped their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. UBS Group initiated coverage on Xylem in a research note on Tuesday, August 13th. They set a “buy” rating and a $165.00 target price on the stock. Finally, Robert W. Baird dropped their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and a consensus target price of $149.64.

Check Out Our Latest Stock Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Articles

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.